Cardinal Health stock had its Relative Strength (RS) Rating upgraded from 66 to 71 Monday — a welcome improvement, but still shy of the 80 or better score you look for.
How To Invest In Stocks In Both Bull And Bear Markets
This exclusive rating from Investor's Business Daily measures share price performance with a 1 (worst) to 99 (best) score. The grade shows how a stock's price behavior over the last 52 weeks compares to all the other stocks in our database.
Over 100 years of market history reveals that the market's biggest winners often have an RS Rating north of 80 in the early stages of their moves. See if Cardinal Health stock can continue to show renewed price strength and clear that threshold.
Is Cardinal Health Stock A Buy?
Cardinal Health stock is working on a consolidation with a 168.44 buy point. See if it can break out in heavy trade.
Taking a look at top and bottom line numbers, Cardinal Health has posted rising EPS growth over the last two quarters. Top line growth has been less impressive, coming in at 0% in the latest report.
Cardinal Health stock holds the No. 4 rank among its peers in the Medical-Wholesale Drugs industry group. Cencora is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
